Amanote Research
Register
Sign In
Pnd153 - Analysis of Responses to Sf-36v2 Items for Patients With Hattr Amyloidosis: Results From a Double-Blind Placebo-Controlled Trial
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.2901
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
A Yarlas
A Sikora Kessler
A Lovley
S Guthrie
M Pollock
MK White
Publisher
Elsevier BV
Related search
Pnd152 - Impact of Inotersen on Generic Health-Related Quality of Life for Patients With Hattr Amyloidosis: Results From a Double-Blind Placebo-Controlled Trial
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd150 - Impact of Inotersen on Condition-Specific Quality of Life (Qol) for Patients With Hattr Amyloidosis: Results From a Double-Blind Placebo-Controlled Trial
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cerebrolysin in Patients With Acute Ischemic Stroke in Asia: Results of a Double-Blind, Placebo-Controlled Randomized Trial
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Prevalence of Comorbidities With Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
A Randomized, Placebo-Controlled, Double-Blind Trial of Sertraline for Postpartum Depression
Psychopharmacology
Pharmacology
Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Fluoxetine for Depression in Diabetes: A Randomized Double-Blind Placebo-Controlled Trial
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Accidental Exposures to Peanut and Other Food Allergens: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
